South Korea Medical Aesthetic Devices Market - Growth, Trends and Forecasts 2017 - 2022

  • ID: 4388361
  • Report
  • Region: South Korea
  • 205 pages
  • Mordor Intelligence
1 of 3
South Korea’s Aesthetic Medical Devices Market accounted for a share of US$ 389 million in 2015. It is expected to reach US$ 948 million by 2020, at a CAGR of 19.5% from 2015 to 2021. North America currently dominates the market for medical aesthetic devices. The region is expected to continue its strong hold during the forecast period. Asia-Pacific region is expected to increase its market share in the future, owing to the increase in awareness among people about the potential benefits of medical aesthetic devices.

Such an escalation in market potential is creating a need to analyze, review, and to forecast the growth of the medical aesthetic device market. Owing to the rapid evolution of market in the use of laser technology, medical device companies, which are able to launch new innovative equipment, will be awarded with huge benefits.
Note: Product cover images may vary from those shown
2 of 3
1. INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
3.1 MARKET DEFINITION
3.2 MARKET DRIVERS
3.2.1 RISING COST OF AESTHETIC PROCEDURES IN OTHER PARTS OF THE WORLD
3.2.2 RISE IN MEDICAL TOURISM IN SOUTH KOREA
3.2.3 INCREASING OBESE POPULATION IN SOUTH KOREA
3.2.4 TECHNOLOGICAL ADVANCEMENTS
3.3 MARKET RESTRAINTS
3.4 MARKET OPPORTUNITIES
3.5 MARKET THREATS
4. PORTERS FIVER FORCES ANALYSIS
4.1 BARGAINING POWER OF SUPPLIERS
4.2 BARGAINING POWER OF CONSUMERS
4.3 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
4.4 THREAT OF SUBSTITUTE PRODUCTS AND SERVICES
4.5 THREAT OF NEW ENTRANTS
5. MARKET SEGMENTATION
5.1 MEDICAL DEVICES MARKET - BY TYPE
5.1.1 LASER BASED TECHNOLOGY
5.1.2 ENERGY BASED TECHNOLOGY
5.2 BY PRODUCTS
5.2.1 AESTHETIC LASERS AND ENERGY DEVICES
5.2.1.1 LASER RESURFACING DEVICES
5.2.1.2 BODY CONTOURING DEVICES
5.2.1.3 AESTHETICS OPHTHALMOLOGY DEVICES
5.2.2 AESTHETIC IMPLANTS
5.2.2.1 BREAST IMPLANTS
5.2.2.2 FACIAL IMPLANTS
5.2.2.3 OTHER IMPLANTS
6. SEGMENTATION BY GEOGRAPHY
6.1. SOUTH KOREA
7. COMPETITIVE LANDSCAPE
7.1 MERGERS AND ACQUISITIONS
7.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
7.3 NEW PRODUCT LAUNCHES
8. COMPANY PROFILES
8.1 ALLERGAN, INC.
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCTS
8.2 CYNOSURE, INC.
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCTS
8.3 JOHNSON & JOHNSON
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCTS
8.4 SOLTA MEDICAL.
8.4.1 COMPANY OVERVIEW
8.4.2 FINANCIALS (VALEANT PHARMACEUTICALS)
8.4.3 PRODUCTS & SERVICES
8.5 GALDERMA PHARMA
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCTS AND SERVICES
8.6 SCITON INC.
8.6.1 COMPANY OVERVIEW
8.6.3 PRODUCTS
8.7 LUMENIS LTD.
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCTS AND SERVICES
8.8 CUTERA, INC.,
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCTS & SERVICES
8.9 SYNERON MEDICAL
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCTS AND DESCRIPTION
8.10 LUTRONIC
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCTS AND SERVICES
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll